<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Franovic A</submitter><funding>NCI NIH HHS</funding><funding>Canadian Institutes of Health Research</funding><pagination>4466-73</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4631634</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(21)</volume><pubmed_abstract>Integrin ?v?3 has been implicated as a driver of aggressive and metastatic disease, and is upregulated during glioblastoma progression. Here, we demonstrate that integrin ?v?3 allows glioblastoma cells to counteract senescence through a novel tissue-specific effector mechanism involving recruitment and activation of the cytoskeletal regulatory kinase PAK4. Mechanistically, targeting either ?v?3 or PAK4 led to emergence of a p21-dependent, p53-independent cell senescence phenotype. Notably, glioblastoma cells did not exhibit a similar requirement for either other integrins or additional PAK family members. Moreover, ?v?3/PAK4 dependence was not found to be critical in epithelial cancers. Taken together, our findings established that glioblastomas are selectively addicted to this pathway as a strategy to evade oncogene-induced senescence, with implications that inhibiting the ?v?3-PAK4 signaling axis may offer novel therapeutic opportunities to target this aggressive cancer.</pubmed_abstract><journal>Cancer research</journal><pubmed_title>Glioblastomas require integrin ?v?3/PAK4 signaling to escape senescence.</pubmed_title><pmcid>PMC4631634</pmcid><funding_grant_id>R01 CA045726</funding_grant_id><funding_grant_id>R01 CA45726</funding_grant_id><funding_grant_id>R01 CA168692</funding_grant_id><pubmed_authors>Elliott KC</pubmed_authors><pubmed_authors>Cheresh DA</pubmed_authors><pubmed_authors>Weis SM</pubmed_authors><pubmed_authors>Camargo MF</pubmed_authors><pubmed_authors>Franovic A</pubmed_authors><pubmed_authors>Seguin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glioblastomas require integrin ?v?3/PAK4 signaling to escape senescence.</name><description>Integrin ?v?3 has been implicated as a driver of aggressive and metastatic disease, and is upregulated during glioblastoma progression. Here, we demonstrate that integrin ?v?3 allows glioblastoma cells to counteract senescence through a novel tissue-specific effector mechanism involving recruitment and activation of the cytoskeletal regulatory kinase PAK4. Mechanistically, targeting either ?v?3 or PAK4 led to emergence of a p21-dependent, p53-independent cell senescence phenotype. Notably, glioblastoma cells did not exhibit a similar requirement for either other integrins or additional PAK family members. Moreover, ?v?3/PAK4 dependence was not found to be critical in epithelial cancers. Taken together, our findings established that glioblastomas are selectively addicted to this pathway as a strategy to evade oncogene-induced senescence, with implications that inhibiting the ?v?3-PAK4 signaling axis may offer novel therapeutic opportunities to target this aggressive cancer.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2020-11-19T15:30:20Z</modification><creation>2019-03-27T02:01:16Z</creation></dates><accession>S-EPMC4631634</accession><cross_references><pubmed>26297735</pubmed><doi>10.1158/0008-5472.CAN-15-0988</doi><doi>10.1158/0008-5472.can-15-0988</doi></cross_references></HashMap>